Health · 1 views
New oral nanomedicine boosts effectiveness of cancer immunotherapies
Although it has transformed cancer immunotherapy, patients usually have low response rates.
Story Brief
Although it has transformed cancer immunotherapy, patients usually have low response rates. In a new study published in Nature Nanotechnology , University of Michigan researchers developed an oral drug that can increase T cells' ability to attack tumors. To do so, they used 3,4-dihydroxybenzoic acid, or DHB, produced by gut bacteria.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- An alternative to bone marrow sampling: Children with sarcomas may be spared a painful procedureContinue reading
- First-in-human pilot trial improves stem cell collection and delivery for sickle cell gene therapyContinue reading
- Acute myeloid leukemia increasingly impacting older adults globallyContinue reading
- Deep sleep brain waves offer protection against Alzheimer's disease, new research showsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow